|
⚲
|
| Keyboard |
| Invus Advisors LLC
✚
|
|
|---|---|
| CIK # | 0001404553, 0001802978 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Scholar Rock Holding Corp | 0.5 | ||
| Kymera Therapeutics Inc | 0.3 | ||
| Erasca Inc | 0.2 | ||
| Edgewise Therapeutics Inc | 0.1 | ||
| BeiGene Ltd | 0.1 | ||
| BCTG Acquisition Corp | 0.1 | ||
| Bicara Therapeutics Inc | 0.1 | ||
| Revolution Medicines Inc | 0.1 | ||
| Arrowhead Research Corp | 0.1 | ||
| Veradermics Inc | 0.1 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001404553] | |
| 3 | [0001404553] | |
| 4 | [0001404553] | |
| 13F-HR | [0001802978] | |
| 13F-NT | [0001802978] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lexicon Pharmaceuticals Inc LXRX
Series A Convertible Preferred Stock · derivative
|
2024-05-10 | Grant | 1,150,922 | $108.50 | 124,875,037 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2024-05-10 | Option exercise | 57,546,100 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Series A Convertible Preferred Stock · derivative
|
2024-05-10 | Option exercise | 1,150,922 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Series A Convertible Preferred Stock
|
2024-03-13 | Grant | 1,150,922 | $108.50 | 124,875,037 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2023-06-05 | Buy | 27,775,050 | $2.60 | 72,215,130 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2022-08-05 | Buy | 2,426,070 | $2.50 | 6,065,175 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2022-08-01 | Buy | 16,173,800 | $2.50 | 40,434,500 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2020-12-16 | Buy | 10,937,500 | $3.20 | 35,000,000 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2018-06-28 | Buy | 57,724 | $12.45 | 718,664 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2018-06-27 | Buy | 125,114 | $12.54 | 1,568,930 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2018-06-25 | Buy | 228,264 | $12.95 | 2,956,019 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2018-06-22 | Buy | 25,461 | $13.36 | 340,159 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2018-06-21 | Buy | 51,600 | $13.27 | 684,732 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2018-06-20 | Buy | 12,391 | $13.28 | 164,552 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2018-06-19 | Buy | 8,982 | $13.45 | 120,808 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2018-06-18 | Buy | 36,584 | $13.06 | 477,787 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2018-06-14 | Buy | 9,200 | $12.66 | 116,472 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2018-06-12 | Buy | 107,023 | $12.83 | 1,373,105 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2018-06-11 | Buy | 98,626 | $12.75 | 1,257,482 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2018-06-08 | Buy | 29,747 | $12.89 | 383,439 |
| showing 20 of 40 most recent transactions | |||||